A detailed history of Commonwealth Equity Services, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 203,374 shares of AZN stock, worth $15.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
203,374
Previous 183,572 10.79%
Holding current value
$15.9 Million
Previous $12.4 Million 11.44%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$61.03 - $69.57 $1.21 Million - $1.38 Million
19,802 Added 10.79%
203,374 $13.8 Million
Q4 2023

Feb 06, 2024

BUY
$61.89 - $69.28 $231,963 - $259,661
3,748 Added 2.08%
183,572 $12.4 Million
Q3 2023

Oct 23, 2023

BUY
$64.85 - $71.7 $13,618 - $15,057
210 Added 0.12%
179,824 $12.2 Million
Q2 2023

Aug 10, 2023

BUY
$69.91 - $75.81 $637,089 - $690,856
9,113 Added 5.34%
179,614 $12.9 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $159,390 - $180,718
2,524 Added 1.5%
170,501 $11.8 Million
Q4 2022

Feb 07, 2023

BUY
$54.21 - $70.44 $324,663 - $421,865
5,989 Added 3.7%
167,977 $11.4 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $229,788 - $588,340
-4,334 Reduced 2.61%
161,988 $8.88 Million
Q2 2022

Jul 19, 2022

BUY
$59.26 - $71.14 $26,311 - $31,586
444 Added 0.27%
166,322 $11 Million
Q1 2022

May 04, 2022

BUY
$55.72 - $67.12 $305,457 - $367,951
5,482 Added 3.42%
165,878 $11 Million
Q4 2021

Jan 31, 2022

SELL
$54.02 - $63.83 $66,444 - $78,510
-1,230 Reduced 0.76%
160,396 $9.34 Million
Q3 2021

Oct 29, 2021

BUY
$55.56 - $60.79 $1.04 Million - $1.14 Million
18,783 Added 13.15%
161,626 $9.71 Million
Q2 2021

Aug 11, 2021

SELL
$48.42 - $60.18 $679,042 - $843,964
-14,024 Reduced 8.94%
142,843 $8.56 Million
Q1 2021

May 04, 2021

SELL
$47.16 - $54.44 $1.3 Million - $1.5 Million
-27,480 Reduced 14.91%
156,867 $7.8 Million
Q4 2020

Feb 11, 2021

SELL
$48.52 - $58.02 $87,093 - $104,145
-1,795 Reduced 0.96%
184,347 $9.22 Million
Q3 2020

Nov 05, 2020

BUY
$53.07 - $61.1 $2.01 Million - $2.32 Million
37,890 Added 25.56%
186,142 $10.2 Million
Q2 2020

Aug 12, 2020

BUY
$43.1 - $55.31 $401,778 - $515,599
9,322 Added 6.71%
148,252 $7.84 Million
Q1 2020

May 11, 2020

SELL
$37.79 - $51.33 $150,782 - $204,806
-3,990 Reduced 2.79%
138,930 $6.2 Million
Q4 2019

Feb 05, 2020

BUY
$42.46 - $50.46 $54,136 - $64,336
1,275 Added 0.9%
142,920 $7.13 Million
Q3 2019

Oct 30, 2019

BUY
$40.12 - $45.47 $177,330 - $200,977
4,420 Added 3.22%
141,645 $6.31 Million
Q2 2019

Jul 19, 2019

BUY
$37.28 - $41.68 $407,582 - $455,687
10,933 Added 8.66%
137,225 $5.66 Million
Q1 2019

May 13, 2019

BUY
$35.49 - $43.02 $71,370 - $86,513
2,011 Added 1.62%
126,292 $5.11 Million
Q4 2018

Feb 11, 2019

BUY
$36.86 - $41.49 $14,227 - $16,015
386 Added 0.31%
124,281 $4.72 Million
Q3 2018

Nov 06, 2018

BUY
$34.76 - $39.72 $120,269 - $137,431
3,460 Added 2.87%
123,895 $4.9 Million
Q2 2018

Jul 31, 2018

SELL
$34.55 - $37.05 $152,987 - $164,057
-4,428 Reduced 3.55%
120,435 $4.23 Million
Q1 2018

May 14, 2018

BUY
$32.97 - $36.63 $135,671 - $150,732
4,115 Added 3.41%
124,863 $4.37 Million
Q4 2017

Feb 12, 2018

BUY
$32.09 - $34.78 $3.87 Million - $4.2 Million
120,748
120,748 $4.19 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $242B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.